PPD’s AES Acquires Global Site Business from Bioclinica

Published on: 

Applied Clinical Trials

Accelerated Enrollment Solutions, a business unit of Pharmaceutical Product Development, LLC, has acquired the clinical research site business of Bioclinica. This  acquisition now expands AES’ global footprint in patient access and site conduct across five continents, 20 countries, over 180 research sites and more than 100 million households.

For more information, click here.